Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
Clinical trial NCT00693472 · TERMINATED
Trial details
- NCT number
- NCT00693472
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-15
- Primary completion
- 2008-12-12
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.